TRI-SPRINTEC

NORGESTIMATE AND ETHINYL ESTRADIOL · Teva Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TRI-SPRINTEC, covering 2013-02-21 to 2023-11-27. Get the full timeline:

Most recent: FDA Approved: TRI-SPRINTEC — Supplemental Application (Teva Pharmaceuticals USA, Inc.)